Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhi-Dong Jiang

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Diabetes Research and Clinical Practice|July 13, 2014
Clostridium difficile infection in diabetesHui-Qi Qu, Zhi-Dong Jiang
Microbial Pathogenesis|December 24, 2018
Occurrence of putative virulence-related genes, aatA, aggR and aaiC, of Enteroaggregative Escherichia coli (EAEC) among adults with travelers' diarrhea acquired in Guatemala and MexicoOluwatosin Bamidele, Zhi-Dong Jiang, Herbert Dupont
The American Journal of Tropical Medicine and Hygiene|January 15, 2009
Improvement in detection of enterotoxigenic Escherichia coli in patients with travelers' diarrhea by increasing the number of E. coli colonies testedThushara Galbadage, Zhi-Dong Jiang, Herbert L DuPont
International Journal of Antimicrobial Agents|January 5, 2010
Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonneiZhi-Dong Jiang, Shi Ke, Herbert L Dupont
The American Journal of Tropical Medicine and Hygiene|December 26, 2003
Association of virulence factor-positive and -negative enteroaggregative Escherichia coli and occurrence of clinical illness in travelers from the United States to MexicoDavid B Huang, Zhi-Dong Jiang, Herbert L Dupont
Journal of Clinical Gastroenterology|April 4, 2008
Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot studyKevin W Garey, Zhi-Dong Jiang, Angelle Bellard, et al.
Current Opinion in Infectious Diseases|August 30, 2008
New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and controlHerbert L DuPont, Kevin Garey, Juan-Pablo Caeiro, et al.
Journal of Medical Virology|April 22, 2006
Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to NorovirusesGwangPyo Ko, Zhi-Dong Jiang, Pablo C Okhuysen, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|December 21, 2016
Electrospun Fibrous Mat with pH-Switchable Superwettability That Can Separate Layered Oil/Water MixturesJin-Jin Li, Yin-Ning Zhou, Zhi-Dong Jiang, et al.
Transactions of the American Clinical and Climatological Association|July 18, 2020
THE INTESTINAL MICROBIOME IN HUMAN HEALTH AND DISEASEHerbert L Dupont, Zhi-Dong Jiang, Andrew W Dupont, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Diabetes Research and Clinical Practice|July 13, 2014
Clostridium difficile infection in diabetesHui-Qi Qu, Zhi-Dong Jiang
Microbial Pathogenesis|December 24, 2018
Occurrence of putative virulence-related genes, aatA, aggR and aaiC, of Enteroaggregative Escherichia coli (EAEC) among adults with travelers' diarrhea acquired in Guatemala and MexicoOluwatosin Bamidele, Zhi-Dong Jiang, Herbert Dupont
The American Journal of Tropical Medicine and Hygiene|January 15, 2009
Improvement in detection of enterotoxigenic Escherichia coli in patients with travelers' diarrhea by increasing the number of E. coli colonies testedThushara Galbadage, Zhi-Dong Jiang, Herbert L DuPont
International Journal of Antimicrobial Agents|January 5, 2010
Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonneiZhi-Dong Jiang, Shi Ke, Herbert L Dupont
The American Journal of Tropical Medicine and Hygiene|December 26, 2003
Association of virulence factor-positive and -negative enteroaggregative Escherichia coli and occurrence of clinical illness in travelers from the United States to MexicoDavid B Huang, Zhi-Dong Jiang, Herbert L Dupont
Journal of Clinical Gastroenterology|April 4, 2008
Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot studyKevin W Garey, Zhi-Dong Jiang, Angelle Bellard, et al.
Current Opinion in Infectious Diseases|August 30, 2008
New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and controlHerbert L DuPont, Kevin Garey, Juan-Pablo Caeiro, et al.
Journal of Medical Virology|April 22, 2006
Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to NorovirusesGwangPyo Ko, Zhi-Dong Jiang, Pablo C Okhuysen, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|December 21, 2016
Electrospun Fibrous Mat with pH-Switchable Superwettability That Can Separate Layered Oil/Water MixturesJin-Jin Li, Yin-Ning Zhou, Zhi-Dong Jiang, et al.
Transactions of the American Clinical and Climatological Association|July 18, 2020
THE INTESTINAL MICROBIOME IN HUMAN HEALTH AND DISEASEHerbert L Dupont, Zhi-Dong Jiang, Andrew W Dupont, et al.
Pageof 11